Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2011 (Vol. 31, No. 1)

CAZy

URL:www.cazy.org
  • Nice links page
  • Nothing significant

If you find yourself in the field of glycoside research, then you’d be “CAZy” not to visit this site! (Cheap humor never gets old…) CAZy, the Carbohydrate-Active enZYmes database, is an online database of (go figure) “CAZymes” that was developed by the Glycogenomics groups at the AFMB (that is, the Architecture et Fonction des Macromolécules Biologiques) in France. So what are CAZymes? These are enzymes involved in the synthesis or breakdown of sugars and their conjugates in the body. Four classes of such enzymes are currently in CAZy: glycoside hydrolases, glycosyltransferases, polysaccharide lyases, and carbohydrate esterases. If any of those names just got you excited, then you’re exactly the type of person who will benefit from this website, which not only includes the database of enzymes but also an extensive list of online glycoside resources.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »